Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Aug;40(8):1785–1789. doi: 10.1128/aac.40.8.1785

Gentamicin concentrations in human subcutaneous tissue.

H Lorentzen 1, F Kallehave 1, H J Kolmos 1, U Knigge 1, J Bülow 1, F Gottrup 1
PMCID: PMC163417  PMID: 8843281

Abstract

Wound infections frequently originate from the subcutaneous tissue. The effect of gentamicin in subcutaneous tissue has, however, normally been evaluated from concentrations in blood or wound fluid. The aim of the present study was to investigate the pharmacokinetic properties of gentamicin in human subcutaneous adipose tissue by a microdialysis technique. Seven healthy young volunteers each had four microdialysis probes placed in the fat (subcutaneous) layer of the abdominal skin. After the administration of a 240-mg gentamicin intravenous bolus, consecutive measurements of the drug concentrations in serum and subcutaneous interstitial fluid were obtained simultaneously for 6 h. The tissue gentamicin concentration peaked after 10 to 30 min. The peak concentration in the tissue was 6.7 +/- 2.0 mg.liter-1 (standard deviation), equivalent to 39.1% of the peak concentration in serum. The area under the concentration-versus-time curve for the first 6 h in the tissue was 1,281 +/- 390.0) mg.min liter-1, equivalent to 59.7% of the area under the concentration-versus-time curve in serum. It is concluded that the microdialysis technique can be used to make dynamic and quantitative measurements of the gentamicin concentration in human subcutaneous tissue. In this adipose tissue, the peak concentrations of gentamicin were approximately seven times the MIC for Pseudomonas aeruginosa and 33 times the MIC for Staphylococcus aureus after the administration of an intravenous bolus of 240 mg, indicating the presence of sufficient concentrations in the adipose tissue to be effective against common bacteria.

Full Text

The Full Text of this article is available as a PDF (205.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aavitsland P., Stormark M., Lystad A. Hospital-acquired infections in Norway: a national prevalence survey in 1991. Scand J Infect Dis. 1992;24(4):477–483. doi: 10.3109/00365549209052634. [DOI] [PubMed] [Google Scholar]
  2. Amberg G., Lindefors N. Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. J Pharmacol Methods. 1989 Nov;22(3):157–183. doi: 10.1016/0160-5402(89)90012-0. [DOI] [PubMed] [Google Scholar]
  3. Arner P., Bolinder J. Microdialysis of adipose tissue. J Intern Med. 1991 Oct;230(4):381–386. doi: 10.1111/j.1365-2796.1991.tb00461.x. [DOI] [PubMed] [Google Scholar]
  4. Benveniste H., Hansen A. J., Ottosen N. S. Determination of brain interstitial concentrations by microdialysis. J Neurochem. 1989 Jun;52(6):1741–1750. doi: 10.1111/j.1471-4159.1989.tb07252.x. [DOI] [PubMed] [Google Scholar]
  5. Benveniste H., Hüttemeier P. C. Microdialysis--theory and application. Prog Neurobiol. 1990;35(3):195–215. doi: 10.1016/0301-0082(90)90027-e. [DOI] [PubMed] [Google Scholar]
  6. Bergan T. Kinetics of tissue penetration. Are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy? Scand J Infect Dis Suppl. 1978;(14):36–46. [PubMed] [Google Scholar]
  7. Blaser J., Stone B. B., Zinner S. H. Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model. Antimicrob Agents Chemother. 1985 Mar;27(3):343–349. doi: 10.1128/aac.27.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bungay P. M., Morrison P. F., Dedrick R. L. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci. 1990;46(2):105–119. doi: 10.1016/0024-3205(90)90043-q. [DOI] [PubMed] [Google Scholar]
  9. Daschner F. Tobramycin serum levels and tissue content in children. Chemotherapy. 1977;23(5):293–298. doi: 10.1159/000221998. [DOI] [PubMed] [Google Scholar]
  10. Eisenberg E. J., Conzentino P., Eickhoff W. M., Cundy K. C. Pharmacokinetic measurement of drugs in lung epithelial lining fluid by microdialysis: aminoglycoside antibiotics in rat bronchi. J Pharmacol Toxicol Methods. 1993 Apr;29(2):93–98. doi: 10.1016/1056-8719(93)90056-k. [DOI] [PubMed] [Google Scholar]
  11. Holm S. E. Experimental models for studies on transportation of antibiotics to extravasal compartments. Scand J Infect Dis Suppl. 1978;(13):47–51. [PubMed] [Google Scholar]
  12. Hori R., Yoshida H., Okumura K. Tissue distribution and metabolism of drugs. IV. Accumulation and penetration of some antibiotics in rat lungs. Chem Pharm Bull (Tokyo) 1979 Jun;27(6):1321–1327. doi: 10.1248/cpb.27.1321. [DOI] [PubMed] [Google Scholar]
  13. Kanke M., Jay M., DeLuca P. Binding of insulin to a continuous ambulatory peritoneal dialysis system. Am J Hosp Pharm. 1986 Jan;43(1):81–88. [PubMed] [Google Scholar]
  14. Leggett J. E., Fantin B., Ebert S., Totsuka K., Vogelman B., Calame W., Mattie H., Craig W. A. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J Infect Dis. 1989 Feb;159(2):281–292. doi: 10.1093/infdis/159.2.281. [DOI] [PubMed] [Google Scholar]
  15. Lönnroth P., Jansson P. A., Fredholm B. B., Smith U. Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans. Am J Physiol. 1989 Feb;256(2 Pt 1):E250–E255. doi: 10.1152/ajpendo.1989.256.2.E250. [DOI] [PubMed] [Google Scholar]
  16. Lönnroth P., Jansson P. A., Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol. 1987 Aug;253(2 Pt 1):E228–E231. doi: 10.1152/ajpendo.1987.253.2.E228. [DOI] [PubMed] [Google Scholar]
  17. Moore R. D., Lietman P. S., Smith C. R. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987 Jan;155(1):93–99. doi: 10.1093/infdis/155.1.93. [DOI] [PubMed] [Google Scholar]
  18. Rauws A. G., van Klingeren B. Estimation of antibiotic levels in interstitial fluid from whole tissue levels. Scand J Infect Dis Suppl. 1978;(14):186–188. [PubMed] [Google Scholar]
  19. Rylander M., Holm S. E., Norrby R., Brorson J. E. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages. Scand J Infect Dis Suppl. 1978;(13):52–57. [PubMed] [Google Scholar]
  20. Schlaeffer F., Blaser J., Laxon J., Zinner S. Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones. J Antimicrob Chemother. 1990 Jun;25(6):941–948. doi: 10.1093/jac/25.6.941. [DOI] [PubMed] [Google Scholar]
  21. Smith D. J., Jr, Thomson P. D. Changing flora in burn and trauma units: historical perspective--experience in the United States. J Burn Care Rehabil. 1992 Mar-Apr;13(2 Pt 2):276–280. doi: 10.1097/00004630-199203000-00020. [DOI] [PubMed] [Google Scholar]
  22. Ståhle L., Arner P., Ungerstedt U. Drug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in man. Life Sci. 1991;49(24):1853–1858. doi: 10.1016/0024-3205(91)90488-w. [DOI] [PubMed] [Google Scholar]
  23. Ståhle L. Pharmacokinetic estimations from microdialysis data. Eur J Clin Pharmacol. 1992;43(3):289–294. doi: 10.1007/BF02333025. [DOI] [PubMed] [Google Scholar]
  24. Ståhle L., Segersvärd S., Ungerstedt U. A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J Pharmacol Methods. 1991 Mar;25(1):41–52. doi: 10.1016/0160-5402(91)90021-v. [DOI] [PubMed] [Google Scholar]
  25. Tredget E. E., Shankowsky H. A., Joffe A. M., Inkson T. I., Volpel K., Paranchych W., Kibsey P. C., Alton J. D., Burke J. F. Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy. Clin Infect Dis. 1992 Dec;15(6):941–949. doi: 10.1093/clind/15.6.941. [DOI] [PubMed] [Google Scholar]
  26. Tsuji A., Miyamoto E., Terasaki T., Yamana T. Physiological pharmacokinetics of beta-lactam antibiotics: penicillin V distribution and elimination after intravenous administration in rats. J Pharm Pharmacol. 1979 Feb;31(2):116–119. doi: 10.1111/j.2042-7158.1979.tb13448.x. [DOI] [PubMed] [Google Scholar]
  27. Vogelman B., Gudmundsson S., Leggett J., Turnidge J., Ebert S., Craig W. A. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis. 1988 Oct;158(4):831–847. doi: 10.1093/infdis/158.4.831. [DOI] [PubMed] [Google Scholar]
  28. Weiner B., McNeely D. J., Kluge R. M., Stewart R. B. Stability of gentamicin sulfate injection following unit dose repackaging. Am J Hosp Pharm. 1976 Dec;33(12):1254–1259. [PubMed] [Google Scholar]
  29. Yamaoka K., Nakagawa T., Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm. 1978 Apr;6(2):165–175. doi: 10.1007/BF01117450. [DOI] [PubMed] [Google Scholar]
  30. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn. 1981 Nov;4(11):879–885. doi: 10.1248/bpb1978.4.879. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES